The North America Synthetic Opioids Market Demand is Anticipated to Witness Steady Growth Owing to Rising Chronic Pain Prevalence
The North America Synthetic Opioids Market Demand is Anticipated to Witness Steady Growth Owing to Rising Chronic Pain Prevalence
Blog Article
The North America synthetic opioids market covers non-pharmaceutical synthetic opioids such as fentanyl that are prescribed for pain management. Synthetic opioids act on the nervous system to block pain signals sent to the brain. The increasing prevalence of chronic pain disorders such as arthritis, cancer, back pain and fibromyalgia have fuelled synthetic opioids demand. Synthetic opioids provide stronger analgesic effects and are preferred alternatives to natural opioids due to their high potency.
According to coherent market Insights the Global North America Synthetic Opioids Market is estimated to be valued at USD 94.16 Bn in 2025 and is expected to reach USD 108.16 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 2.0% from 2025 to 2032.
Key Takeaways
Key players operating in the North America synthetic opioids are copyright, Janssen Pharmaceuticals, West-Ward Pharmaceuticals, Mallinckrodt, Mylan and Purdue Pharma.
Some of the key opportunities in the synthetic opioids market include pipeline products with novel drug delivery systems and abuse-deterrent opioid formulations. Large players are also expanding their synthetic opioids manufacturing operations across Latin America and Asia Pacific to tap higher growth markets.
Government initiatives aimed at addressing the chronic pain epidemic through appropriate pain management are also boosting synthetic opioids demand.
Market drivers
The growing geriatric population who are more susceptible to chronic diseases is driving the demand for synthetic opioids in pain management. According to estimates, over 50% of elderly citizen’s experiences chronic pain. Additionally, the increased awareness about benefits of synthetic opioids in managing moderate to severe pain compared to other alternatives is positively impacting the market revenues.
Market restrain
Stringent regulations around opioid prescribing owing to abuse and overdose risks pose a major challenge to market players. Similarly, the availability of alternative pain medications like cannabinoids also restrains market potential to a certain extent.
Segment Analysis
The North America Synthetic Opioids Market Demand can be segmented based on type and application. Based on type, the fentanyl sub-segment currently dominates the market. Fentanyl is a powerful synthetic opioid pain medication with around 50-100 times the potency of morphine. It is predominantly prescribed for the treatment of severe pain, especially chronic pain. Some of the factors contributing to fentanyl's market dominance include its high potency, wide acceptance among healthcare professionals for pain management, and prevalent usage for managing chronic cancer pain. The tramadol sub-segment is expected to grow at a steady pace during the forecast period.
Global Analysis
Regionally, the United States holds the major share of the North America synthetic opioids market and is anticipated to continue its dominance over the forecast period. This can be attributed to factors such as the rising prevalence of chronic pain disorders, growing acceptability of synthetic opioids for cancer pain management, increasing number of surgical procedures performed, and presence of advanced healthcare systems. copyright is projected to witness the fastest growth rate during the period owing to growing geriatric population, rising healthcare expenditure, and increasing focus on effective pain management. However, regulatory barriers and strict prescription policies may restrain the market to a certain extent across some regions.
Get More Insights On- North America Synthetic Opioids Market
Get This Report In Japanese-
Get This Report In Korean-
Read More Blog Related to this Industry- 3D Printing in Medical Sector- An Endless Sea of Lifesaving Possibilities Waiting to Be Explored
About Author:
Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.
( LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91 )
copyright src="chrome-extension://fpjppnhnpnknbenelmbnidjbolhandnf/content_script_web_accessible/ecp_regular.js" type="text/javascript"> Report this page